Breaking News on Biopharmaceutical Development & Manufacturing

Top Headlines

LegoChem signs up Novimmune as latest ADC licensee

LegoChem Biosciences has teamed up with Novimmune to develop and test antibody drug conjugate (ADC) drug.

TxCell raises cash for first-in-man CAR-Treg cell therapy study

TxCell has raised €11m through a share issue which it will use to fund first-in-man study of one of its cell therapy candidates.

Ohr Pharmaceutical Inc. shuts sustained release tech lab

Ohr Pharmaceutical Inc. has halted activities at the laboratory in San Diego, California where research on its sustained release delivery technology was carried out.

Celltrion's MabThera cleared by EC for autoimmune diseases and cancer

The European Commission has approved Celltrion Healthcare’s rituximab biosimilar – Truxima (CT-P10) – for the same autoimmune disease and cancer indications as the reference product.

Belgian CAR-T biotech enrols first blood cancer patient in new trial

Celyad SA has enrolled the first multiple myeloma patient in a safety and tolerability trial of its CAR-T therapy.


Raging bull' - Vaccines don’t cause autism and saying otherwise costs lives

Vaccines do not cause autism and people who say otherwise are wrong.

CRB sister Discovery launches second antibody catalogue

Cambridge Research Biochemicals (CRB) has launched a second catalogue of research antibodies for academia, pharma and outsourcing firms.

Promotional Features

Key Industry Events


Access all events listing

Our events, Shows & Conferences...